摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-Chlorophenyl)-3-(7-hydroxynaphthalen-1-yl)urea | 497149-28-7

中文名称
——
中文别名
——
英文名称
1-(2-Chlorophenyl)-3-(7-hydroxynaphthalen-1-yl)urea
英文别名
——
1-(2-Chlorophenyl)-3-(7-hydroxynaphthalen-1-yl)urea化学式
CAS
497149-28-7
化学式
C17H13ClN2O2
mdl
——
分子量
312.755
InChiKey
ZZRAIFAJILLITB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    429.9±25.0 °C(Predicted)
  • 密度:
    1.459±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    22
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    61.4
  • 氢给体数:
    3
  • 氢受体数:
    2

反应信息

  • 作为产物:
    参考文献:
    名称:
    Naphthol derivatives as TRPV1 inhibitors for the treatment of urinary incontinence
    摘要:
    We have identified naphthol derivatives as inhibitors of the vanilloid receptor TRPV1 by high throughput screening. The initial lead showed high clearance in rats and has been optimized by enhancing the acidity of the phenol group. Compound 6b has reduced clearance, improved potency and is active in rat cystometry models of urinary incontinence after intravenous administration. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.04.013
点击查看最新优质反应信息

文献信息

  • Naphthol derivatives as TRPV1 inhibitors for the treatment of urinary incontinence
    作者:Klaus Urbahns、Takeshi Yura、Muneto Mogi、Masaomi Tajimi、Hiroshi Fujishima、Tsutomu Masuda、Nagahiro Yoshida、Toshiya Moriwaki、Timothy B. Lowinger、Heinrich Meier、Fiona Chan、David Madge、Jang B. Gupta
    DOI:10.1016/j.bmcl.2011.04.013
    日期:2011.6
    We have identified naphthol derivatives as inhibitors of the vanilloid receptor TRPV1 by high throughput screening. The initial lead showed high clearance in rats and has been optimized by enhancing the acidity of the phenol group. Compound 6b has reduced clearance, improved potency and is active in rat cystometry models of urinary incontinence after intravenous administration. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多